Jennifer Madonia

Assessment of ¹⁸F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy

Matthias Brendel, Henryk Barthel, Thilo van Eimeren et al. · JAMA Neurology · 2020 · 253 citations · Full text

Medicine, Neurology, Nuclear Medicine +15

Tau PET imaging with ¹⁸F-PI-2620 in Patients with Alzheimer Disease and Healthy Controls: A First-in-Humans Study

André Mueller, Santiago Bullich, Olivier Barret et al. · Journal of Nuclear Medicine · 2019 · 200 citations · Full text

Medicine, Neurology, Nuclear Medicine +17

Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial

Richard B. Lipton, Robert Croop, David Stock et al. · The Lancet Neurology · 2023 · 145 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double‐blind, randomized, placebo‐controlled, dose‐ranging trial

Robert Croop, Jennifer Madonia, David Stock et al. · Headache The Journal of Head and Face Pain · 2022 · 99 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Early-phase [18F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injury

Leonie Beyer, Alexander Nitschmann, Henryk Barthel et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 66 citations · Full text

Medicine, Neuroscience, Radiology +17